More data on hormone therapy and coronary heart disease: Comments on recent publications from the WHI and Nurses' Health Study

Climacteric

Volumn 9, Issue 2, 2006, Pages 75-76

  Pines, Amos ^a   Sturdee, David W ^a   Birkhäuser, Martin ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; PROGESTERONE;

ATHEROSCLEROSIS; CLIMACTERIUM; DEMOGRAPHY; EARLY MENOPAUSE; FEMALE; HEART PROTECTION; HORMONAL THERAPY; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; NOTE; PRIORITY JOURNAL; RISK REDUCTION;

AGE FACTORS; AGED; CORONARY ARTERIOSCLEROSIS; ESTROGEN REPLACEMENT THERAPY; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MIDDLE AGED;

EID: 33646490573     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.1080/13697130600655415     Document Type: Note

References (3)

1. The Women' Health Initiative Steering Committee. Effects of conjugated estrogen on postmenopausal women with hysterectomy: the Women' Health Initiative randomized controlled trial. JAMA 2004;291:1701-12
2. Hsia J, Langer RD, Manson JE, et al. Conjugated equine estrogens and coronary heart disease. The Women's Health Initiative. Arch Intern Med 2006;166:357-65
3. Grodstein F, Manson JE, Stampfer MJ. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation. J Women's Health 2006;15:35-44